<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Torrent Pharmaceuticals Limited — News on 6ix</title>
<link>https://6ix.com/company/torrent-pharmaceuticals-limited</link>
<description>Latest news and press releases for Torrent Pharmaceuticals Limited on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Sat, 21 Mar 2026 18:00:19 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/torrent-pharmaceuticals-limited" rel="self" type="application/rss+xml" />
<item>
<title>Press Release Mar 21 2026</title>
<link>https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-mar-21-2026-1</link>
<guid isPermaLink="true">https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-mar-21-2026-1</guid>
<pubDate>Sat, 21 Mar 2026 18:00:19 GMT</pubDate>
<description>Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 21, 2026, titled " Torrent Pharma launches oral and injectable formulations of Semaglutide".</description>
</item>
<item>
<title>Xeris Biopharma Subsidiaries File Recorlev® Patent Infringement Lawsuit</title>
<link>https://6ix.com/company/torrent-pharmaceuticals-limited/news/xeris-biopharma-subsidiaries-file-recorlevr-patent-infringement-lawsuit-1</link>
<guid isPermaLink="true">https://6ix.com/company/torrent-pharmaceuticals-limited/news/xeris-biopharma-subsidiaries-file-recorlevr-patent-infringement-lawsuit-1</guid>
<pubDate>Thu, 26 Feb 2026 22:55:00 GMT</pubDate>
<description>CHICAGO, February 26, 2026--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, announced that its subsidiaries, Xeris Pharmaceuticals, Inc. and Strongbridge Dublin Limited, have filed a patent infringement lawsuit under the Hatch-Waxman Act related to Recorlev® (levoketoconazole) in the United States District Court for the District of New Je</description>
</item>
<item>
<title>Press Release Feb 13 2026</title>
<link>https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-feb-13-2026-1</link>
<guid isPermaLink="true">https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-feb-13-2026-1</guid>
<pubDate>Fri, 13 Feb 2026 22:06:30 GMT</pubDate>
<description>Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "A Press Release on Financial Results which is being submitted to the media is also enclosedherewith".</description>
</item>
<item>
<title>Press Release Nov 07 2025</title>
<link>https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-nov-07-2025-1</link>
<guid isPermaLink="true">https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-nov-07-2025-1</guid>
<pubDate>Fri, 07 Nov 2025 22:52:42 GMT</pubDate>
<description>Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 07, 2025, titled "Press Release - Financial Results Q2".</description>
</item>
<item>
<title>Press Release Jul 28 2025</title>
<link>https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-jul-28-2025-1</link>
<guid isPermaLink="true">https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-jul-28-2025-1</guid>
<pubDate>Mon, 28 Jul 2025 20:37:55 GMT</pubDate>
<description>Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 28, 2025, titled "Press Release".</description>
</item>
<item>
<title>Press Release May 20 2025</title>
<link>https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-may-20-2025-2</link>
<guid isPermaLink="true">https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-may-20-2025-2</guid>
<pubDate>Tue, 20 May 2025 21:43:56 GMT</pubDate>
<description>Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 20, 2025, titled "A Press Release on Financial Results which is being submitted to the media is also enclosedherewith".</description>
</item>
<item>
<title>Press Release Jan 24 2025</title>
<link>https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-jan-24-2025-2</link>
<guid isPermaLink="true">https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-jan-24-2025-2</guid>
<pubDate>Fri, 24 Jan 2025 22:37:00 GMT</pubDate>
<description>Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 24, 2025, titled "A Press Release on Financial Results which is being submitted to the media is also enclosedherewith".</description>
</item>
<item>
<title>Press Release Dec 04 2024</title>
<link>https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-dec-04-2024-2</link>
<guid isPermaLink="true">https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-dec-04-2024-2</guid>
<pubDate>Wed, 04 Dec 2024 23:18:37 GMT</pubDate>
<description>Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 04, 2024, titled "Torrent Pharma enters into an agreement with Boehringer Ingelheim to acquire 3 anti-diabetes brands".</description>
</item>
<item>
<title>Press Release Oct 25 2024</title>
<link>https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-oct-25-2024-2</link>
<guid isPermaLink="true">https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-oct-25-2024-2</guid>
<pubDate>Fri, 25 Oct 2024 21:25:44 GMT</pubDate>
<description>Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 25, 2024, titled "A Press Release on Financial Results which is being submitted to the media is also enclosedherewith.".</description>
</item>
<item>
<title>Press Release Sep 26 2024</title>
<link>https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-sep-26-2024</link>
<guid isPermaLink="true">https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-sep-26-2024</guid>
<pubDate>Thu, 26 Sep 2024 22:09:48 GMT</pubDate>
<description>Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 26, 2024, titled "Torrent Pharmaceuticals Limited (Torrent) refutes claims of Shelcal 500 allegedlyfailing CDSCO quality test".</description>
</item>
<item>
<title>Press Release Jun 05 2024</title>
<link>https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-jun-05-2024</link>
<guid isPermaLink="true">https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-jun-05-2024</guid>
<pubDate>Wed, 05 Jun 2024 19:30:10 GMT</pubDate>
<description>Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 05, 2024, titled "Torrent Pharmaceuticals Enters into Non-Exclusive Patent Licensing Agreement with Takeda Pharmaceuticals to Commercialize its Novel Gastrointestinal Drug in India".</description>
</item>
<item>
<title>Press Release Feb 02 2024</title>
<link>https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-feb-02-2024-2</link>
<guid isPermaLink="true">https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-feb-02-2024-2</guid>
<pubDate>Fri, 02 Feb 2024 19:11:04 GMT</pubDate>
<description>Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 02, 2024, titled "A Press Release on Financial Results which is being submitted to the media is also enclosedherewith as Annexure-B.".</description>
</item>
<item>
<title>Press Release Nov 10 2023</title>
<link>https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-nov-10-2023</link>
<guid isPermaLink="true">https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-nov-10-2023</guid>
<pubDate>Fri, 10 Nov 2023 19:50:26 GMT</pubDate>
<description>Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 10, 2023, titled "Torrent and Zydus sign licensing agreement for co-marketing Saroglitazar Mg, a critical treatment for chronic liver diseases in India".</description>
</item>
<item>
<title>Press Release Aug 24 2023</title>
<link>https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-aug-24-2023-1</link>
<guid isPermaLink="true">https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-aug-24-2023-1</guid>
<pubDate>Thu, 24 Aug 2023 14:46:29 GMT</pubDate>
<description>Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 24, 2023, titled "Torrent Pharmaceuticals gets EIR from US FDA for Dahej facility".</description>
</item>
<item>
<title>Press Release Aug 07 2023</title>
<link>https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-aug-07-2023-1</link>
<guid isPermaLink="true">https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-aug-07-2023-1</guid>
<pubDate>Tue, 08 Aug 2023 00:59:24 GMT</pubDate>
<description>Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 07, 2023, titled "Press Release on Financial Results".</description>
</item>
<item>
<title>Press Release May 30 2023</title>
<link>https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-may-30-2023-1</link>
<guid isPermaLink="true">https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-may-30-2023-1</guid>
<pubDate>Tue, 30 May 2023 21:25:45 GMT</pubDate>
<description>Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 30, 2023, titled "A Press Release on Financial Results which is being submitted to the media is also enclosed herewith".</description>
</item>
<item>
<title>Press Release Jan 25 2023</title>
<link>https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-jan-25-2023-3</link>
<guid isPermaLink="true">https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-jan-25-2023-3</guid>
<pubDate>Wed, 25 Jan 2023 21:44:46 GMT</pubDate>
<description>Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 25, 2023, titled "A Press Release on Financial Results which is being submitted to the media is also enclosedherewith.".</description>
</item>
<item>
<title>Press Release Dec 14 2022</title>
<link>https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-dec-14-2022-2</link>
<guid isPermaLink="true">https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-dec-14-2022-2</guid>
<pubDate>Wed, 14 Dec 2022 20:36:56 GMT</pubDate>
<description>Torrent Pharmaceuticals Limited has informed the Exchange about press release dated 14-Dec-2022 titled Torrent Pharmaceuticals Ltd enters into co-marketing partnership with Boehringer Ingelheim India Private Limited to co- market its anti-diabetic drug and its fixed dose combinations in India</description>
</item>
<item>
<title>Press Release Sep 27 2022</title>
<link>https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-sep-27-2022-1</link>
<guid isPermaLink="true">https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-sep-27-2022-1</guid>
<pubDate>Tue, 27 Sep 2022 19:34:52 GMT</pubDate>
<description>Torrent Pharmaceuticals Limited has informed the Exchange about press release dated 27-Sep-2022 titled Torrent Pharma to acquire Curatio Healthcare</description>
</item>
<item>
<title>Press Release Jul 29 2022</title>
<link>https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-jul-29-2022</link>
<guid isPermaLink="true">https://6ix.com/company/torrent-pharmaceuticals-limited/news/press-release-jul-29-2022</guid>
<pubDate>Fri, 29 Jul 2022 22:20:12 GMT</pubDate>
<description>Torrent Pharmaceuticals Limited has informed the Exchange about press release dated 29-Jul-2022 titled Torrent Pharma announces Q1 FY23 results</description>
</item>
</channel>
</rss>